Latest

neuropharmacology

·December 1, 2022·4 min read

Multiple Sclerosis Therapy Found to Also Improve Gut Flora

Multiple sclerosis patients treated with dimethyl fumarate (Tecfidera) showed a reduced proportion of pro-inflammatory types of gut bacteria and an increased growth of "good" bacteria after three months of treatment.

Featured Neurology Neuroscience

·November 30, 2022·4 min read

Alzheimer’s Amyloid-Clearing Monoclonal Antibody Drug Lecanemab Shows Positive Results, Poised for FDA Approval

Lecanemab, an amyloid-clearing monoclonal antibody drug shows positive results in the treatment of Alzheimer's disease. The drug is now poised for FDA approval early in 2023. Lecanemab slows cognitive decline by 27%.

Featured Neurology Neuroscience

·November 30, 2022·4 min read

Controversial Alzheimer’s Drug Approval Sparks Surprising Impact

Media coverage of the FDA-approved Alzheimer's drug aducanumab made the public less willing to volunteer in Alzheimer's pharmaceutical trials.

Featured Neurology Neuroscience

·November 21, 2022·3 min read

NSAIDs May Worsen Arthritis Inflammation

Taking NSAIDs such as ibuprofen or naproxen for arthritis may make inflammation worse over time, a new study reports.

Featured Neurology Neuroscience

·November 18, 2022·4 min read

A Connection Between Diabetes Medications and Multiple Sclerosis

People over the age of 45 who use anti-hyperglycemic medications to control their Type 2 diabetes are at increased risk of developing multiple sclerosis. However, those who are under 45 and take anti-hyperglycemic medications are at reduced risk of MS.

This shows Vyvanse (Lisdexamfetamine) 70mg capsules

Featured Neuroscience Psychology

·November 17, 2022·5 min read

ADHD Medication for Amphetamine Addiction Linked to Reduced Risk of Hospitalization and Death

Lisdexamfetamine (Vyvanse), a medication commonly used to treat ADHD, lowers the risk of hospitalization and death for those with amphetamine use disorder.

Brain Cancer Featured Neuroscience

·November 16, 2022·8 min read

Implanted Pump Safely Delivered Chemo Straight to the Brain in Patients With Brain Cancer

A new implantable pump system safely and effectively bypasses the blood-brain barrier to deliver chemotherapy drugs to those with glioblastoma brain cancer.

This shows the outline of a woman's head

Featured Neuroscience Psychology

·November 14, 2022·4 min read

Fentanyl Vaccine Potential ‘Game Changer’ for Opioid Epidemic

A newly developed vaccine blocks the ability of the opioid Fentanyl's ability to enter the brain, thus blocking the drug's "high".

Featured Neuroscience Visual Neuroscience

·November 8, 2022·4 min read

Cholesterol and Diabetes Drugs May Lessen Risk of Age Related Macular Degeneration

A new study reports regular usage of medications to control type 2 diabetes and lower cholesterol may decrease the risk of developing age-related macular degeneration.

This shows a brain slice with serotonin neurons in the Nca highlighted

Featured Neuroscience Psychology

·November 4, 2022·6 min read

Serotonin Key to Social Aversion During Withdrawal From Opioids

Opioid withdrawal cuts off the supply of serotonin to the nucleus accumbens, dramatically reducing sociability in mice and increasing social aversion.

Featured Neurology Neuroscience

·November 4, 2022·4 min read

Blood Pressure Drug Could Be a Potential Treatment for Black Patients With Alzheimer’s

Black people are almost twice as likely to develop Alzheimer's disease later in life than white people. Researchers report Telmisartan, a drug used to treat high blood pressure by blocking angiotensin II, appears to be helpful in preventing or treating Alzheimer's disease in Black individuals. The drug did not show the same potential in white people.

Featured Neurology Neuroscience

·October 24, 2022·4 min read

Oxytocin Derivative Improves Cognitive Impairment in Alzheimer’s

An intranasally delivered oxytocin derivative helped improve cognitive function and reduced cognitive impairment in mouse models of Alzheimer's disease.